Wilson Wolf Manufacturing, LLC
We create hope for cancer patients, one device at a time.
We create hope for cancer patients, one device at a time.
Wilson Wolf Manufacturing, LLC is a biotechnology startup founded in 1998 with a mission to bring hope to cancer patients through innovative cell culture devices. Their flagship product, G-Rex® bioreactors, is tailored for rapid expansion of immune cell types, particularly in the field of T cell therapy, which has shown promising clinical results for previously untreatable cancer types.
Recently, the company secured a significant $257.00M investment in a Corporate Round from Bio-Techne on 01 March 2023. This substantial investment reflects a strong recognition of Wilson Wolf's potential in the biotechnology industry.
Furthermore, Wilson Wolf has formed a strategic partnership with Fresenius Kabi and Bio-Techne to establish ScaleReady, a commercialization organization dedicated to providing scalable cell therapy manufacturing solutions. This partnership signifies a commitment to simplifying T cell manufacturing and offering innovative industry-leading solutions.
As an investor, the combination of Wilson Wolf's expertise in T cell therapy manufacturing and their successful partnerships with industry leaders such as Fresenius Kabi and Bio-Techne presents a compelling opportunity in the rapidly growing field of cell therapy and biotechnology. This recent investment is poised to propel Wilson Wolf Manufacturing, LLC to the forefront of the biotechnology industry, making it an enticing prospect for venture capital consideration.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Corporate Round | $257.00M | 1 | Bio-Techne | 01 Mar 2023 |
No recent news or press coverage available for Wilson Wolf Manufacturing, LLC.
We care about your data, and we'd love to use cookies make your experience better.